Lineage Cell Therapeutics

News

Business handshake lines and triangles, point connecting network on blue background. Illustration vector

The ins and outs of the life sciences: top hires for October...

In this new segment from pharmaphorum, we collect the most significant hirings, firings, and recruitment stories from across the industry.

News

JPM: AbbVie pays $650m upfront for RemeGen cancer drug

AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Lineage Cell Therapeutics

Editor's Picks